Delivery Order SPE2DR25D2103-SPE2DR26F91RC
- Not listed
- The Defense Logistics Agency awarded a $36,704.63 delivery order to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of Dupixent 300 mg/2 ml pen injectors. This is a firm fixed-price, non-set-aside contract with a completion date of November 7, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract...
- The Defense Logistics Agency awarded a $32,178 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 ml pen injectors, with an ultimate completion date of October 22, 2025. This non-set-aside contract represents a single delivery order under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor...
- The Defense Logistics Agency awarded a $26,459.82 delivery order to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 mL pen injectors, with an ultimate completion date of September 22, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a $22,797.54 delivery order to AmerisourceBergen Drug Corp on November 10, 2025, for the supply of Dupixent 300 mg/2 mL pen injectors. This is a firm fixed-price, competitively awarded contract with no set-aside designation, scheduled for completion by November 12, 2025. The product will be delivered to AmerisourceBergen's corporate headquarters location in Conshohocken, Pennsylvania. This delivery order is issued under the company's existing Indefinite...
- The Defense Logistics Agency awarded a $105,802.94 delivery order to AmerisourceBergen Drug Corp on November 7, 2025, for the supply of Dupixent 300 mg/2 ml pen injectors. This non-set-aside, firm fixed-price contract is expected to be completed by November 10, 2025, with performance centered at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop...
- The Defense Logistics Agency awarded a $35,898.66 delivery order to AmerisourceBergen Drug Corp on October 29, 2025, for the supply of Dupixent 300 mg/2 ml pen injectors. This is a firm fixed price, competitively awarded contract with no set-aside designation and a completion date of October 30, 2025. The delivery order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child contract action, this delivery order falls under...
- The Defense Logistics Agency awarded a $29,562.50 delivery order to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 mL pen injectors on November 17, 2025, with an ultimate completion date of November 18, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement and operates as a child contract under the company's...
- The Defense Logistics Agency awarded a delivery order valued at $22,972.76 to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 mL pen injectors on August 14, 2025, with completion expected by August 15, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $5,987.47 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml pen injectors on August 5, 2025, with an ultimate completion date of August 6, 2025. This competitive award, issued under firm fixed pricing, represents a child contract to AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The place of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 17, 2025, for the supply of Dupixent 300 mg/2 mL pen injectors with a contract ceiling value of $46,951.54. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of November 18, 2025. As a child contract, this delivery...
- SPE2DR25D2103Indefinite Delivery Contract
- SPE2DR25D2103-SPE2DR26F91RCDelivery Order
The Defense Logistics Agency awarded a $38,959.95 delivery order to AmerisourceBergen Drug Corp on November 18, 2025, for the supply of Dupixent 300 mg/2 ml pen injectors (2 ml). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of November 19, 2025. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor agreement running through December 2026 that serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen's contract portfolio with the Defense Logistics Agency demonstrates its critical role in supplying pharmaceutical products and medical supplies to support military and veteran healthcare systems. The company's federal awards encompass a broad range of therapeutic categories including specialty medications, brand-name and generic drugs, and medical devices. The DLA Troop Support Medical prime vendor contract enables AmerisourceBergen to deliver pharmaceuticals and medical commodities to support the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems worldwide. This specific delivery order for Dupixent, a biologic used to treat conditions such as atopic dermatitis and eosinophilic asthma, reflects the company's ongoing role in fulfilling specialized pharmaceutical requirements for federal healthcare procurement.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $39.0k | 11/18/25 |